The cost of kidney cancer treatment in Turkey varies depending on the specific procedures and medical needs of the patient. Initial diagnostics, including consultations with medical oncologists and radiologists, range from $200 to $1,300. For surgical interventions, a laparoscopic radical nephrectomy can cost around $11,000, while a more advanced robotic surgery might reach up to $24,000. Additionally, a kidney transplant procedure is estimated at $19,000, inclusive of all necessary medical assessments and hospital stay. The overall treatment plan is tailored based on the patient"s condition and the detailed evaluation by the medical team.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,957 |
| Nephrectomy with Da Vinci Robot | from $10,000 | from $16,000 | from $20,000 |
| Nephrectomy | from $10,000 | from $22,000 | from $15,000 |
| NanoKnife | from $9,500 | from $25,000 | from $12,000 |
Prof. Bülent Karagöz specializes in tumor biology and immunotherapy with 33 years of experience of experience, treating kidney cancer at Anadolu Medical Center.
Ranked 3rd in Turkey for oncology – Dr. Tanrikulu brings precise expertise to kidney cancer treatment at Anadolu Medical Center.
Dr. Solak brings specialized training from Hacettepe University Cancer Institute and extensive experience with diverse cancers, including kidney cases at Hisar Hospital Intercontinental.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.